Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Adaptive Study of the Safety and Efficacy of RDC-0313 in Adults With Alcohol Dependence

NCT00981617 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT00981617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Adaptive Study of the Safety and Efficacy of RDC-0313 in Adults With Alcohol Dependence
Lead sponsor
Alkermes, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
August 31, 2010
Enrollment
406 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence